RhumbLine Advisers’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-25,183
Closed -$15.6K 4369
2024
Q2
$15.6K Sell
25,183
-102,240
-80% -$63.2K ﹤0.01% 3907
2024
Q1
$327K Buy
127,423
+3,747
+3% +$9.63K ﹤0.01% 2937
2023
Q4
$252K Sell
123,676
-545
-0.4% -$1.11K ﹤0.01% 3070
2023
Q3
$214K Sell
124,221
-5,832
-4% -$10K ﹤0.01% 3128
2023
Q2
$254K Buy
+130,053
New +$254K ﹤0.01% 3109
2022
Q2
Sell
-56,865
Closed -$234K 3266
2022
Q1
$234K Buy
56,865
+1,170
+2% +$4.82K ﹤0.01% 2718
2021
Q4
$716K Buy
55,695
+3,566
+7% +$45.8K ﹤0.01% 2353
2021
Q3
$563K Buy
52,129
+1,900
+4% +$20.5K ﹤0.01% 2489
2021
Q2
$459K Buy
50,229
+13,837
+38% +$126K ﹤0.01% 2600
2021
Q1
$343K Sell
36,392
-2,100
-5% -$19.8K ﹤0.01% 2650
2020
Q4
$152K Buy
38,492
+7,072
+23% +$27.9K ﹤0.01% 2900
2020
Q3
$83K Sell
31,420
-5,396
-15% -$14.3K ﹤0.01% 2903
2020
Q2
$244K Buy
36,816
+6,563
+22% +$43.5K ﹤0.01% 2675
2020
Q1
$176K Buy
30,253
+1,950
+7% +$11.3K ﹤0.01% 2630
2019
Q4
$254K Buy
28,303
+250
+0.9% +$2.24K ﹤0.01% 2672
2019
Q3
$242K Buy
28,053
+2,774
+11% +$23.9K ﹤0.01% 2679
2019
Q2
$282K Buy
+25,279
New +$282K ﹤0.01% 2631